tyrosine kinases inhibitor Latest Research Papers

Regionally surgical resection of stage-IV adenocarcinoma acquired tyrosine kinases inhibitor-resistance

Journal of Thoracic Disease ◽

10.21037/jtd.2018.12.105 ◽

2019 ◽

Vol 11 (1) ◽

pp. 255-258 ◽

Cited By ~ 1

Author(s):

Minglei Yang ◽

Enkuo Zheng ◽

Xiang Xu ◽

Junjun Ni ◽

Junfang Li ◽

...

Keyword(s):

Surgical Resection ◽

Tyrosine Kinases ◽

Stage Iv ◽

Inhibitor Resistance ◽

Tyrosine Kinases Inhibitor

Download Full-text

Midostaurin: A Multiple Tyrosine Kinases Inhibitor in Acute Myeloid Leukemia and Systemic Mastocytosis

Small Molecules in Hematology - Recent Results in Cancer Research ◽

10.1007/978-3-319-91439-8_10 ◽

2018 ◽

pp. 199-214 ◽

Cited By ~ 4

Author(s):

Richard F. Schlenk ◽

Sabine Kayser

Keyword(s):

Acute Myeloid Leukemia ◽

Tyrosine Kinases ◽

Myeloid Leukemia ◽

Systemic Mastocytosis ◽

Acute Myeloid ◽

Tyrosine Kinases Inhibitor

Download Full-text

318 Effects of Radiologic Tumor Response of Anti-Glypican-3 GC33 and Multi Tyrosine Kinases Inhibitor Sorafenib in Hepatocellular Carcinoma

European Journal of Cancer ◽

10.1016/s0959-8049(12)72116-0 ◽

2012 ◽

Vol 48 ◽

pp. 97 ◽

Cited By ~ 1

Author(s):

G.K. Abou-Alfa ◽

B. Zhao ◽

J.F. Chou ◽

J. Ma ◽

M. Capanu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Tyrosine Kinases ◽

Tumor Response ◽

Tyrosine Kinases Inhibitor

Download Full-text

Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1681-1 ◽

2011 ◽

Vol 69 (1) ◽

pp. 173-183 ◽

Cited By ~ 2

Author(s):

Dongchun Wang ◽

Feng Tang ◽

Sen Wang ◽

Zhenzhou Jiang ◽

Luyong Zhang

Keyword(s):

Tyrosine Kinases ◽

Receptor Tyrosine Kinases ◽

Anti Tumor Activity ◽

Tyrosine Kinases Inhibitor

Download Full-text

SU11248, A selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells

Cancer Biology & Therapy ◽

10.4161/cbt.10.7.12904 ◽

2010 ◽

Vol 10 (7) ◽

pp. 703-711 ◽

Cited By ~ 20

Author(s):

Emily Young ◽

Lucio Miele ◽

Kevan B. Tucker ◽

Min Huang ◽

Jeremy Wells ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Tumor Angiogenesis ◽

Tyrosine Kinases ◽

Breast Tumor ◽

Breast Cancer Cells ◽

Tumor Vasculature ◽

Tyrosine Kinases Inhibitor

Download Full-text

SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells

The FASEB Journal ◽

10.1096/fasebj.24.1_supplement.774.1 ◽

2010 ◽

Vol 24 (S1) ◽

Author(s):

Jian‐Wei Gu ◽

Kevan B Tucker ◽

Min Huang ◽

Emily Young ◽

Jeremy Wells ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Tumor Angiogenesis ◽

Tyrosine Kinases ◽

Breast Tumor ◽

Breast Cancer Cells ◽

Tumor Vasculature ◽

Tyrosine Kinases Inhibitor

Download Full-text

53LBA A phase I/IIa study of icotinib hydrochloride (BPI-2009H), an oral epidermal growth factor receptor tyrosine kinases inhibitor, in patients with advanced non-small-cell lung cancer and other solid tumors

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)72088-9 ◽

2009 ◽

Vol 7 (3) ◽

pp. 22

Author(s):

Q. Zhao ◽

J. Zhou ◽

J. Shentu ◽

L. Wu ◽

N. Xu ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Tyrosine Kinases ◽

Receptor Tyrosine Kinases ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Tyrosine Kinases Inhibitor

Download Full-text

tyrosine kinases inhibitor
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Regionally surgical resection of stage-IV adenocarcinoma acquired tyrosine kinases inhibitor-resistance

Midostaurin: A Multiple Tyrosine Kinases Inhibitor in Acute Myeloid Leukemia and Systemic Mastocytosis

318 Effects of Radiologic Tumor Response of Anti-Glypican-3 GC33 and Multi Tyrosine Kinases Inhibitor Sorafenib in Hepatocellular Carcinoma

Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor

SU11248, A selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells

SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells

53LBA A phase I/IIa study of icotinib hydrochloride (BPI-2009H), an oral epidermal growth factor receptor tyrosine kinases inhibitor, in patients with advanced non-small-cell lung cancer and other solid tumors

Export Citation Format

tyrosine kinases inhibitorRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Regionally surgical resection of stage-IV adenocarcinoma acquired tyrosine kinases inhibitor-resistance

Midostaurin: A Multiple Tyrosine Kinases Inhibitor in Acute Myeloid Leukemia and Systemic Mastocytosis

318 Effects of Radiologic Tumor Response of Anti-Glypican-3 GC33 and Multi Tyrosine Kinases Inhibitor Sorafenib in Hepatocellular Carcinoma

Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor

SU11248, A selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells

SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells

53LBA A phase I/IIa study of icotinib hydrochloride (BPI-2009H), an oral epidermal growth factor receptor tyrosine kinases inhibitor, in patients with advanced non-small-cell lung cancer and other solid tumors

tyrosine kinases inhibitor
Recently Published Documents